Asset Management One Co. Ltd. grew its holdings in Varian Medical Systems, Inc. (NYSE:VAR) by 22.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,583 shares of the medical equipment provider’s stock after acquiring an additional 13,910 shares during the period. Asset Management One Co. Ltd. owned about 0.08% of Varian Medical Systems worth $10,153,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also bought and sold shares of the business. Geode Capital Management LLC grew its stake in shares of Varian Medical Systems by 7.2% during the fourth quarter. Geode Capital Management LLC now owns 1,259,504 shares of the medical equipment provider’s stock worth $142,479,000 after purchasing an additional 84,116 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Varian Medical Systems by 3.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 355,174 shares of the medical equipment provider’s stock valued at $40,242,000 after acquiring an additional 12,271 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Varian Medical Systems by 1,791.9% in the first quarter. Victory Capital Management Inc. now owns 25,540 shares of the medical equipment provider’s stock valued at $3,620,000 after acquiring an additional 24,190 shares in the last quarter. First Allied Advisory Services Inc. purchased a new stake in shares of Varian Medical Systems in the first quarter valued at about $227,000. Finally, Stratos Wealth Partners LTD. purchased a new stake in shares of Varian Medical Systems in the first quarter valued at about $210,000. Institutional investors and hedge funds own 91.22% of the company’s stock.
In other Varian Medical Systems news, Director Timothy E. Guertin sold 12,651 shares of the firm’s stock in a transaction on Monday, July 15th. The shares were sold at an average price of $135.21, for a total transaction of $1,710,541.71. Following the completion of the transaction, the director now directly owns 13,589 shares of the company’s stock, valued at approximately $1,837,368.69. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP John W. Kuo sold 465 shares of the firm’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $116.30, for a total transaction of $54,079.50. Following the transaction, the senior vice president now directly owns 35,411 shares of the company’s stock, valued at $4,118,299.30. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,046 shares of company stock worth $1,878,876. 0.78% of the stock is currently owned by insiders.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 24th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.18. Varian Medical Systems had a net margin of 10.75% and a return on equity of 24.91%. The firm had revenue of $825.80 million for the quarter, compared to analyst estimates of $762.29 million. During the same quarter last year, the business earned $1.04 earnings per share. Varian Medical Systems’s revenue was up 16.5% compared to the same quarter last year. On average, analysts anticipate that Varian Medical Systems, Inc. will post 4.63 earnings per share for the current fiscal year.
A number of equities research analysts have recently commented on VAR shares. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a report on Wednesday, July 24th. Robert W. Baird set a $158.00 target price on shares of Varian Medical Systems and gave the company a “buy” rating in a report on Friday, July 26th. Barrington Research upped their target price on shares of Varian Medical Systems from $142.00 to $146.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. TheStreet cut shares of Varian Medical Systems from a “b” rating to a “c+” rating in a report on Monday, August 5th. Finally, Zacks Investment Research cut shares of Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 target price for the company. in a report on Saturday, July 27th. One analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. Varian Medical Systems currently has a consensus rating of “Hold” and a consensus target price of $141.67.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Featured Article: How do analysts define an oversold condition?
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.